uniQure (QURE) Work In Process (2022 - 2024)
uniQure's (QURE) quarterly Work In Process came in at $1.3 million in Q1 2024, down 67.36% quarter-over-quarter from $4.1 million in Q4 2023.
uniQure (QURE) Work In Process (2022 - 2024) Analysis & Trends
uniQure's Work In Process history runs 3 years deep, the most recent figure standing at $1.3 million for Q1 2024.
- On a quarterly basis, Work In Process changed N/A year-over-year to $1.3 million in Q1 2024; TTM through Mar 2024 was $1.3 million, a N/A change from a year earlier, with the FY2023 full-year figure at $4.1 million, up 119.26% from the prior year.
- Work In Process fell to $1.3 million in Q1 2024 per QURE's latest filing, from $4.1 million in the prior quarter.
- Across five years, Work In Process topped out at $6.6 million in Q3 2023 and bottomed at $1.3 million in Q1 2024.
- The 3-year median for Work In Process is $3.1 million (2022), against an average of $3.4 million.
- Biggest YoY gain for Work In Process was 202.89% in 2023; the steepest drop was 119.26% in 2023.
- Year by year, Work In Process stood at $1.9 million in 2022, then jumped by 119.26% to $4.1 million in 2023, then tumbled by 67.36% to $1.3 million in 2024.
- Per Business Quant, the three latest QURE Work In Process figures stand at $1.3 million (Q1 2024), $4.1 million (Q4 2023), and $6.6 million (Q3 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 4.11 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 4.06 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 2.18 Mn |